Anna Polli

9.4k citations
63 papers · 7.2k · 6 hit papers · h-index 26

Impact in

    • Lung Cancer Treatments and Mutations
    • Brain Metastases and Treatment
    • Advanced Breast Cancer Therapies
    • Lung Cancer Diagnosis and Treatment
    • Breast Cancer Treatment Studies
    • Cancer Genomics and Diagnostics

Papers in

Anna Polli

59 papers receiving 6.9k citations

Anna Polli's Hit Papers

Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study 2024 · 190 citations
1900+10+21Years since publication5001k1.5k2k2.5k

Peers

Anna Polli
Comparison fields: 5 of 105
  • Pulmonary and Respiratory Medicine 4.4k
  • Cancer Research 1.2k
  • Endocrinology, Diabetes and Metabolism 575
  • Oncology 678
  • Genetics 628
Replace Luigi Dogliotti with:
Luigi Dogliotti Italy
S. Ashley United Kingdom
Giorgio Massimini Italy
Thian San Kheoh United States
Meritxell Bellet Spain
Alan Webster United Kingdom
Giorgio Cocconi Italy
Lucy Kilburn United Kingdom
Rudolf Maibach Switzerland
István Láng Hungary
Anna Polli relative to Luigi Dogliotti Italy Luigi Dogliotti's profile →
Citations per field
00.5×2×2.9×
Luigi Dogliotti · 1×
Citations per year

Countries citing papers authored by Anna Polli

Since Specialization
Citations

This map shows the geographic impact of Anna Polli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Polli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Polli more than expected).

Fields of papers citing papers by Anna Polli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Polli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Polli. The network helps show where Anna Polli may publish in the future.

Co-authors

The 25 scholars most cited alongside Anna Polli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anna Polli Line = papers co-authored together Anna Polli links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Crizotinib versus Chemotherapy in Advanced ALK -Positive Lung Cancer
Hit paper breakdown →
20132903
2
First-Line Lorlatinib or Crizotinib in Advanced ALK -Positive Lung Cancer
Hit paper breakdown →
2020817
3
A Comparison of Cabergoline and Bromocriptine in the Treatment of Hyperprolactinemic Amenorrhea
Hit paper breakdown →
1994541
4
Clinical Experience With Crizotinib in Patients With Advanced ALK-Rearranged Non–Small-Cell Lung Cancer and Brain Metastases
Hit paper breakdown →
2015528
5 2000439
6 2000270
7 2005245
8
Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study
Hit paper breakdown →
2024190
9
Efficacy and safety of first-line lorlatinib versus crizotinib in patients with advanced, ALK-positive non-small-cell lung cancer: updated analysis of data from the phase 3, randomised, open-label CROWN study
Hit paper breakdown →
2022166
10 199997
11 202295
12 201790
13 200689
14 201262
15 199253
16 200053
17 201752
18 201249
19 201644
20 202340

About Anna Polli

Anna Polli is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Genetics, Oncology and Molecular Biology, having authored 63 papers that have together received 7.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (38 papers), Estrogen and related hormone effects (11 papers), Breast Cancer Treatment Studies (10 papers), Advanced Breast Cancer Therapies (9 papers), Melanoma and MAPK Pathways (8 papers), Bone health and treatments (4 papers), Pituitary Gland Disorders and Treatments (3 papers) and Bone health and osteoporosis research (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (4.4k citations), Cancer Research (1.2k citations), Endocrinology, Diabetes and Metabolism (575 citations), Oncology (678 citations) and Genetics (628 citations). Anna Polli has collaborated with scholars based in United States, Italy and France. Frequent co-authors include Benjamin Solomon, Alice Tsang Shaw, Gabriella Piscitelli, Tony S.K. Mok, Carlo I. Ferrari, Ikram Shah Ismail, Maurice F. Scanlon, Todd Michael Bauer, Dong‐Wan Kim and Geoffrey Liu. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, Journal of Clinical Oncology, Journal of Thoracic Oncology and Future Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact